Diederik F.S. Kehrer

Modulation of irinotecan-induced diarrhea by cotreatment with neomycin in cancer patients.

Diederik F.S. Kehrer, Alex Sparreboom, Jaap Verweij et al. · PubMed · 2001 · 175 citations

Gastrointestinal Pharmacology, Gastroenterology, Pathology +16

Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial

Vivianne C. G. Tjan‐Heijnen, Irene E.G. van Hellemond, Petronella G.M. Peer et al. · The Lancet Oncology · 2017 · 157 citations

Medicine, Clinical Trials, Gynecology +10

Modulation of Irinotecan Metabolism by Ketoconazole

Diederik F.S. Kehrer, Ron H.J. Mathijssen, Jaap Verweij et al. · Journal of Clinical Oncology · 2002 · 120 citations

Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings

Stefan Kubicka, Richard Greil, Thierry André et al. · Annals of Oncology · 2013 · 101 citations · Full text

Gastrointestinal Oncology, Medicine, Pathology +8

Prophylaxis of Irinotecan-Induced Diarrhea with Neomycin and Potential Role for <b> <i>UGT1A1*28</i> </b> Genotype Screening: A Double-Blind, Randomized, Placebo-Controlled Study

Floris A. de Jong, Diederik F.S. Kehrer, Ron H.J. Mathijssen et al. · The Oncologist · 2006 · 88 citations · Full text